tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
US Market
MNPR
Monopar Therapeutics Inc
RESEARCH TOOLSreports

Monopar Therapeutics Inc (MNPR) Financial Statements

571 Followers

Monopar Therapeutics Inc Financial Overview

Monopar Therapeutics Inc's market cap is currently $375.30M. The company's EPS TTM is $-0.64; its P/E ratio is -35.28; Monopar Therapeutics Inc is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -16.70M$ -16.16M$ -8.83M$ -10.54M$ -9.13M
EBITDA$ -16.70M$ -16.16M$ -8.83M$ -10.54M$ -9.13M
Net Income$ -13.72M$ -15.59M$ -8.40M$ -10.52M$ -9.10M
Balance Sheet
Cash & Short-Term Investments$ 61.83B$ 60.21M$ 7.27M$ 13.12M$ 20.30M
Total Assets$ 140.72B$ 60.29M$ 7.35M$ 13.23M$ 20.52M
Total Debt$ 154.92M$ 0.00$ 0.00$ 8.41K$ 0.00
Net Debt$ -61.68B$ -45.82M$ -7.27M$ -8.18M$ -20.30M
Total Liabilities$ 2.89B$ 5.25M$ 1.76M$ 3.14M$ 1.58M
Stockholders' Equity$ 137.83B$ 55.04M$ 5.59M$ 10.09M$ 18.94M
Cash Flow
Free Cash Flow$ -12.20B$ -6.40M$ -7.86M$ -7.23M$ -7.32M
Operating Cash Flow$ -12.20B$ -6.40M$ -7.86M$ -7.23M$ -7.32M
Investing Cash Flow$ -63.45B$ -14.34M$ 4.93M$ -4.92M$ 0.00
Financing Cash Flow$ 91.57B$ 59.29M$ 2.03M$ 32.87K$ 10.88M
Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Income Statement >

Monopar Therapeutics Inc Debt to Assets

Balance Sheet >

Monopar Therapeutics Inc Cash Flow

Cash Flow >

Monopar Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >